文献速递肾小球疾病

IgA血管炎肾炎肾脏结局的组织学与临床相关因素

Histologic and Clinical Factors Associated with Kidney Outcomes in IgA Vasculitis Nephritis.
PubMed 文献 · Clin J Am Soc Nephrol · 2024-01-23

该研究纳入来自北美、欧洲和亚洲23个中心的361例IgA血管炎肾炎患者(262例儿童和99例成人),由三名病理学家独立评分MEST-C。多数患者(309例,86%)接受免疫抑制治疗,采用潜在类别混合模型分析eGFR轨迹,中位随访2.7年。结果显示E1和纤维性新月体与肾脏结局相关,这些特征不属于国际儿童疾病研究分类。

要点

  • E1是唯一与不良eGFR轨迹独立相关的MEST-C评分成分。
  • 纤维性新月体(无活动性改变)与稳定eGFR轨迹相关。
  • 年龄≤18岁、男性、活检时eGFR较低和肾外非皮肤疾病也与不良轨迹相关。

核心结论

  • 在接受免疫抑制治疗的活检IgA血管炎肾炎患者中,肾脏结局由临床危险因素、内皮细胞增生(E1)和纤维性新月体决定。

研究设计与样本

  • 多中心回顾性队列研究,纳入北美、欧洲和亚洲23个中心的361例IgA血管炎肾炎患者(262例儿童和99例成人)。
  • 活检由三名病理学家独立评分MEST-C,评估其与活检时eGFR/蛋白尿的相关性。
  • 在309例(86%)接受免疫抑制治疗的患者中,采用潜在类别混合模型识别eGFR轨迹类别,中位随访2.7年(四分位距1.2-5.1年)。
  • 使用逻辑回归确定与每个轨迹类别相关的临床和组织学参数。

主要发现

  • M、E、T和C评分与活检时eGFR或蛋白尿相关。
  • 潜在类别混合模型识别出两个类别:类别1(N=91)eGFR初期改善后晚期下降,类别2(N=218)eGFR稳定。
  • 类别1与更高的确立肾脏结局风险相关(eGFR下降≥30%或肾衰竭时间;风险比5.84;95%置信区间2.37至14.4)。
  • 多变量分析中,仅E1与类别1相关;其他与类别1相关的因素包括年龄18岁及以下、男性、活检时eGFR较低和肾外非皮肤疾病。
  • 纤维性新月体(无活动性改变)与类别2相关。

临床怎么用

  • 在活检IgA血管炎肾炎患者中,应关注E1评分和纤维性新月体,以评估肾脏预后。
  • 临床因素如年龄、性别、活检时eGFR和肾外非皮肤疾病也应纳入风险评估。

局限性

  • 大多数患者(86%)接受免疫抑制治疗,结果可能主要适用于该人群。
  • 研究为回顾性设计,可能存在选择偏倚。
  • 随访时间中位2.7年,可能不足以评估长期结局。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Nephritis is a common manifestation of IgA vasculitis and is morphologically indistinguishable from IgA nephropathy. While MEST-C scores are predictive of kidney outcomes in IgA nephropathy, their value in IgA vasculitis nephritis has not been investigated in large multiethnic cohorts. METHODS: Biopsies from 262 children and 99 adults with IgA vasculitis nephritis ( N =361) from 23 centers in North America, Europe, and Asia were independently scored by three pathologists. MEST-C scores were assessed for correlation with eGFR/proteinuria at biopsy. Because most patients ( N =309, 86%) received immunosuppression, risk factors for outcomes were evaluated in this group using latent class mixed models to identify classes of eGFR trajectories over a median follow-up of 2.7 years (interquartile range, 1.2-5.1). Clinical and histologic parameters associated with each class were determined using logistic regression. RESULTS: M, E, T, and C scores were correlated with either eGFR or proteinuria at biopsy. Two classes were identified by latent class mixed model, one with initial improvement in eGFR followed by a late decline (class 1, N =91) and another with stable eGFR (class 2, N =218). Class 1 was associated with a higher risk of an established kidney outcome (time to ≥30% decline in eGFR or kidney failure; hazard ratio, 5.84; 95% confidence interval, 2.37 to 14.4). Among MEST-C scores, only E1 was associated with class 1 by multivariable analysis. Other factors associated with class 1 were age 18 years and younger, male sex, lower eGFR at biopsy, and extrarenal noncutaneous disease. Fibrous crescents without active changes were associated with class 2. CONCLUSIONS: Kidney outcome in patients with biopsied IgA vasculitis nephritis treated with immunosuppression was determined by clinical risk factors and endocapillary hypercellularity (E1) and fibrous crescents, which are features that are not part of the International Study of Diseases of Children classification.

来源:Clin J Am Soc Nephrol,查看原文。版权归原作者所有。

引用

  1. Barbour SJ, Coppo R, Er L, et al. Histologic and Clinical Factors Associated with Kidney Outcomes in IgA Vasculitis Nephritis. Clin J Am Soc Nephrol. 2024. PMID: 38261310. doi:10.2215/CJN.0000000000000398

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。